TOP NEWS
POLICY & REGULATION
ENFORCEMENT & COMPLIANCE
LITIGATION
DEALS
PEOPLE
EXPERT ANALYSIS
LEGAL INDUSTRY
Kirkland Stops Repping Novartis After Regeneron Sought DQ
By Bryan Koenig
A New York federal judge accepted the withdrawal Thursday of the entire Kirkland & Ellis LLP team that recently joined Novartis Pharma's legal team battling antitrust allegations over the eye medication Eylea, just a week after plaintiff Regeneron Pharmaceuticals sought their disqualification over an "unthinkable" conflict of interest by the lawyers, whose firm previously represented Regeneron.
2 documents attached |
Read full article »
| Save to favorites »
|